登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 7372 条符合本次的查询结果， 用时 1.3483191 秒

7081. Department of Error.

来源: Lancet. 2021年397卷10275期670页

7082. Department of Error.

来源: Lancet. 2021年397卷10275期670页

7083. Iron deficiency in PREVENTT.

作者: Anastazia Keegan.;Philip Crispin.;Amanda Ormerod.;Kristen Brown.;Christine Akers.;Fiona King.
来源: Lancet. 2021年397卷10275期669页

7084. Iron deficiency in PREVENTT.

作者: Bernd Froessler.;Elizabeth Murphy.;Nicolette Hodyl.
来源: Lancet. 2021年397卷10275期668页

7085. Iron deficiency in PREVENTT.

作者: Axel Hofmann.;Irwin Gross.;Domenico Girelli.;Matti Aapro.;Donat R Spahn.
来源: Lancet. 2021年397卷10275期668-669页

7086. Why the global health community should support the EndSARS movement in Nigeria.

作者: Nnenaya A Mmonu.;Angela Aifah.;Deborah Onakomaiya.;Gbenga Ogedegbe.
来源: Lancet. 2021年397卷10275期666-667页

7087. The Health Index for England.

作者: Jonathan Pearson-Stuttard.;Sally C Davies.
来源: Lancet. 2021年397卷10275期665页

7088. Global need: including rehabilitation in health system strengthening.

作者: Tiago S Jesus.;Michel D Landry.
来源: Lancet. 2021年397卷10275期665-666页

7089. Sharrelle Barber: at the intersection of place, race, and health.

作者: Pamela Das.
来源: Lancet. 2021年397卷10275期659页

7090. Research Focus: The Cleveland Clinic at 100.

作者: Talha Burki.
来源: Lancet. 2021年397卷10275期658页

7091. Severe mental illness: reassessing COVID-19 vaccine priorities.

作者: Nayanah Siva.
来源: Lancet. 2021年397卷10275期657页

7092. von der Leyen admits to COVID-19 vaccine failures.

作者: Rob Hyde.
来源: Lancet. 2021年397卷10275期655-656页

7093. Offline: What is the UK for?

作者: Richard Horton.
来源: Lancet. 2021年397卷10275期654页

7094. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.

作者: Sharon Amit.;Gili Regev-Yochay.;Arnon Afek.;Yitshak Kreiss.;Eyal Leshem.
来源: Lancet. 2021年397卷10277期875-877页

7095. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.

作者: Michael J Mina.;Tim E Peto.;Marta García-Fiñana.;Malcolm G Semple.;Iain E Buchan.
来源: Lancet. 2021年397卷10283期1425-1427页

7096. Department of Error.

来源: Lancet. 2021年397卷10276期796页

7097. Future scenarios for the COVID-19 pandemic.

作者: David Skegg.;Peter Gluckman.;Geoffrey Boulton.;Heide Hackmann.;Salim S Abdool Karim.;Peter Piot.;Christiane Woopen.
来源: Lancet. 2021年397卷10276期777-778页

7098. Cabozantinib: a new first-line option for papillary renal cell carcinoma?

作者: Delphine Borchiellini.;Philippe Barthélémy.
来源: Lancet. 2021年397卷10275期645-647页

7099. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.

作者: Sumanta K Pal.;Catherine Tangen.;Ian M Thompson.;Naomi Balzer-Haas.;Daniel J George.;Daniel Y C Heng.;Brian Shuch.;Mark Stein.;Maria Tretiakova.;Peter Humphrey.;Adebowale Adeniran.;Vivek Narayan.;Georg A Bjarnason.;Ulka Vaishampayan.;Ajjai Alva.;Tian Zhang.;Scott Cole.;Melissa Plets.;John Wright.;Primo N Lara.
来源: Lancet. 2021年397卷10275期695-703页
MET (also known as hepatocyte growth factor receptor) signalling is a key driver of papillary renal cell carcinoma (PRCC). Given that no optimal therapy for metastatic PRCC exists, we aimed to compare an existing standard of care, sunitinib, with the MET kinase inhibitors cabozantinib, crizotinib, and savolitinib for treatment of patients with PRCC.

7100. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.

作者: .; .; .; .
来源: Lancet. 2021年397卷10278期947-950页
共有 7372 条符合本次的查询结果， 用时 1.3483191 秒